Meet the Team
A company is only as strong as its team. Meet the dedicated professionals who are the backbone of our organization.
Mrs. Kalpna Mehta
Founder/Chairperson
KD Yamasaki
As the Chairperson of KD Yamasaki, Mrs. Kalpna Mehta is a dynamic and visionary leader, with nearly a decade of experience driving innovation in the health and wellness industry. Her remarkable journey—from entrepreneurial ventures to leading KD Yamasaki—embodies her unwavering commitment to advancing healthcare through groundbreaking solutions.
​
Kalpna’s strategic leadership has been integral in positioning KD Yamasaki at the forefront of healthcare transformation. Collaborating closely with Mr. Masafumi Yamasaki, she has been pivotal in turning innovative concepts into impactful healthcare solutions that challenge the conventional.
​
Her dedication to fostering a culture of excellence and collaboration empowers KD Yamasaki's team to push the boundaries of what's possible, creating a lasting impact on global health. Kalpna’s forward-thinking vision continues to shape the future of healthcare, inspiring change and improving lives across the world.
Dr. Masafumi Yamasaki
Chief Medical Officer (CMO)
KD Yamasaki
Dr. Masafumi Yamasaki is a global pioneer in integrating AI technology with traditional chiropractic practices, driving innovation in neurological care. With over 50 years of experience, his contributions have had a profound impact on healthcare worldwide.
​
Starting his journey in 1972 at the Meiji Acupuncture Bonesetter School in Japan, Dr. Yamasaki found his true calling in chiropractic care after attending a seminar in 1975. He further refined his expertise under the mentorship of Dr. Walter Pierce in Pittsburgh, developing groundbreaking techniques that set new standards in physical medicine. In 1992, he revolutionized the field with the creation of a computer-assisted treatment system, earning international recognition.
​
Dr. Yamasaki’s innovative methods have inspired medical professionals across the globe, particularly in Europe, the Middle East, and India. He continues to shape the future of healthcare through KD Yamasaki, blending decades of clinical expertise with AI technology to redefine patient care.​ A respected figure in the medical community, Dr. Yamasaki's vision and legacy remain at the core of KD Yamasaki, driving its mission to deliver precision and transformative care worldwide.
Ms. Dharmee Mehta
Chief Executive Officer (CEO)
KD Yamasaki
Ms. Dharmee Mehta is the visionary CEO of KD Yamasaki, leading the company with a unique blend of expertise in healthcare and technology. Her passion for understanding the human mind and her extensive experience in the healthcare field shape her forward-thinking leadership at the helm of the company.
​
Dharmee’s journey with KD Yamasaki began over a decade ago, training under Mr. Masafumi Yamasaki, where she developed a unique perspective on integrating psychology with medical technology. As CEO, she has transformed KD Yamasaki into a globally recognized leader in healthcare innovation, setting strategic direction, driving operational efficiency, and fostering a collaborative culture focused on excellence.
​
Under Dharmee’s leadership, KD Yamasaki has evolved into a movement, shaping the future of healthcare through groundbreaking innovations that impact lives worldwide. With her visionary approach, Dharmee continues to lead the company to new heights, pushing boundaries and redefining standards of care.
Mr. John Crunick
President
Sigma Instruments, Inc
Mr. John Crunick is a leader and the founder of Sigma Instruments, Inc., an industry leader in computerized low-energy resonance technology. With his expert guidance, Sigma has expanded its reach to over 30 countries and developed groundbreaking medical devices like the rRSW™ and rFAP™, technologies that have been integral to the treatment of over 16 million patients annually, with an impeccable record of safety and no reported adverse events.
​
A dynamic force in research and development, product innovation, and global expansion, John has been at the forefront of Sigma’s rise as a leader in non-invasive physical medicine solutions. His career spans decades of executive management and engineering, enabling Sigma to revolutionize the healthcare industry with cutting-edge technologies.
​
Since the 2022 acquisition by KD Yamasaki, John has played a pivotal role in merging Sigma's groundbreaking technologies with KD Yamasaki’s vision, contributing to the development of next-generation therapeutic systems that integrate AI and precision diagnostics. John's ongoing leadership continues to shape the future of healthcare, advancing the integration of technology and medical innovation on a global scale.